These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1673135)

  • 1. Symposium on restenosis: from basic studies to clinical trials.
    J Am Coll Cardiol; 1991 May; 17(6 Suppl B):1B-194B. PubMed ID: 1673135
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of restenosis.
    Casscells W; Engler D; Willerson JT
    Tex Heart Inst J; 1994; 21(1):68-77. PubMed ID: 8180514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Restenosis after angioplasty. "Excessive cicatrization"? Diagnosis, management and perspectives].
    Konstadinidis T
    Arq Bras Cardiol; 1993 Jul; 61(1):57-61. PubMed ID: 8285869
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group.
    Erbel R; Haude M; Höpp HW; Franzen D; Rupprecht HJ; Heublein B; Fischer K; de Jaegere P; Serruys P; Rutsch W; Probst P
    N Engl J Med; 1998 Dec; 339(23):1672-8. PubMed ID: 9834304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Percutaneous transluminal angioplasty and restenosis--working hypothesis and treatment approaches].
    Roeren T
    Rontgenpraxis; 1996 Feb; 49(2):31-4. PubMed ID: 8851545
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group.
    Weintraub WS; Boccuzzi SJ; Klein JL; Kosinski AS; King SB; Ivanhoe R; Cedarholm JC; Stillabower ME; Talley JD; DeMaio SJ
    N Engl J Med; 1994 Nov; 331(20):1331-7. PubMed ID: 7935702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot findings of a percutaneous transluminal coronary angioplasty-restenosis-prone prevention program.
    Goodman M
    Mayo Clin Proc; 1997 May; 72(5):487. PubMed ID: 9146696
    [No Abstract]   [Full Text] [Related]  

  • 9. Morphologic observations late after coronary balloon angioplasty: mechanisms of acute injury and relationship to restenosis.
    Waller BF; Orr CM; Pinkerton CA; VanTassel JW; Pinto RP
    Radiology; 1990 Mar; 174(3 Pt 2):961-7. PubMed ID: 2406792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restenosis: the "hole" truth?
    King SB
    J Am Coll Cardiol; 1995 Sep; 26(3):703. PubMed ID: 7642862
    [No Abstract]   [Full Text] [Related]  

  • 11. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.
    Tardif JC; Cöté G; Lespérance J; Bourassa M; Lambert J; Doucet S; Bilodeau L; Nattel S; de Guise P
    N Engl J Med; 1997 Aug; 337(6):365-72. PubMed ID: 9241125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of fish oil to prevent coronary angioplasty restenosis.
    Mauro VF; Frazee LA
    Ann Pharmacother; 1992 Dec; 26(12):1541-5. PubMed ID: 1482813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphometric and histologic assessment of remodeling associated with restenosis after percutaneous transluminal coronary angioplasty.
    Nakamura Y; Zhao H; Yutani C; Imakita M; Ishibashi-Ueda H
    Cardiology; 1998 Oct; 90(2):115-21. PubMed ID: 9778548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restenosis after transluminal coronary angioplasty: a risk factor analysis.
    Gürlek A; Dağalp Z; Oral D; Omürlü K; Erol C; Akyol T; Tutar E
    J Cardiovasc Risk; 1995 Feb; 2(1):51-5. PubMed ID: 7606641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Restenosis after coronary angioplasty: status in 1994].
    Vojácek J
    Vnitr Lek; 1995 May; 41(5):325-31. PubMed ID: 7653063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of residual plaque burden after balloon angioplasty in the MultiVitamins and Probucol (MVP) trial.
    Tardif JC; Côté G; Lespérance J; Gosselin G; Joyal M; de Guise P; Bilodeau L; Doucet S; Harel F; Couturier A; Gallo R; Grégoire J
    Can J Cardiol; 2001 Jan; 17(1):49-55. PubMed ID: 11173314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Restenosis and arterial remodelling after coronary angioplasty].
    Jørgensen B; Forfang K
    Tidsskr Nor Laegeforen; 1996 Aug; 116(20):2460-3. PubMed ID: 8928109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine as a risk factor for restenosis after coronary angioplasty.
    Morita H; Kurihara H; Kuwaki T; Hamada C; Kitaoka M; Suzuki S; Yazaki Y; Nagai R
    Thromb Haemost; 2000 Jul; 84(1):27-31. PubMed ID: 10928465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials?
    Lafont A; Faxon D
    Cardiovasc Res; 1998 Jul; 39(1):50-9. PubMed ID: 9764189
    [No Abstract]   [Full Text] [Related]  

  • 20. [Complications of coronary angioplasty].
    Buffet P; Juillière Y; Cherrier F
    Presse Med; 1993 May; 22(18):870-5. PubMed ID: 8337218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.